Immatics beruft Biotech-Experten Eliot Forster in den Aufsichtsrat
September 15, 2020 07:00 ET
|
Immatics N.V.
Tübingen, Deutschland und Houston, Texas, 15. September 2020 – Immatics N.V. (NASDAQ: IMTX; „Immatics“), ein Unternehmen, das sich auf die Entwicklung und Herstellung von T-Zell-Immuntherapien für die...
Immatics veröffentlicht Update zu ACTengine®-Zelltherapieprogramm IMA204 gegen eine Tumor-Stroma-Zielstruktur
September 10, 2020 07:00 ET
|
Immatics N.V.
Tübingen, Deutschland und Houston, Texas, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Das ACTengine®-Zelltherapieprogramm IMA204 adressiert COL6A3 Exon 6, eine neuartige Zielstruktur, die im...
Immatics Provides Update on IMA204 ACTengine® Cell Therapy Program Targeting the Tumor Microenvironment
September 10, 2020 07:00 ET
|
https://immatics.com/
Tuebingen, Germany and Houston, Texas, Sept. 10, 2020 (GLOBE NEWSWIRE) -- IMA204 ACTengine® cell therapy program directed at novel tumor target COL6A3 exon 6 prevalently expressed at high copy...
AlloVir Appoints Ercem Atillasoy, M.D., as Chief Regulatory and Safety Officer
September 08, 2020 16:15 ET
|
AlloVir Inc.
CAMBRIDGE, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced the appointment of Ercem Atillasoy, M.D., as the company’s Chief...
Worldwide Cell Therapy Industry to 2025 - North America is Leading the Cell Therapy Market
September 07, 2020 05:38 ET
|
Research and Markets
Dublin, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy Market- Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The cell therapy market...
Immatics veröffentlicht Ergebnisse des zweiten Quartals 2020 sowie Informationen zur Geschäftsentwicklung
September 03, 2020 07:00 ET
|
Immatics N.V.
Tübingen, Deutschland und Houston, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Abschluss der Fusion mit ARYA Life Science Acquisition Corp. sowie anschließende Börsennotierung an der NASDAQ im...
Immatics Announces Second Quarter 2020 Financial Results and Business Update
September 03, 2020 07:00 ET
|
https://immatics.com/
Tuebingen, Germany and Houston, TX, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Completed merger with ARYA Life Science Acquisition Corp. and subsequent NASDAQ listing with proceeds from the transaction...
Viral Vector Manufacturing Industry by Type, Application, End-user and Region - Forecast to 2025
August 31, 2020 07:04 ET
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The global viral vector...
BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020
August 26, 2020 07:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies today...
AlloVir to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
August 25, 2020 07:30 ET
|
AlloVir Inc.
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present a corporate overview at the virtual Morgan Stanley 18th...